Data on the percentage of patients admitted to hospital with COVID-19 and for other reasons is attached. Data is only available for England from August 2020 \u2013 January 2021.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/1293256/answer/attachment/1", "fileName" : {"_value" : "PQ160659 - final data - Copy.xlsx"} , "title" : "Admissions data 2020-2021"} , "dateOfAnswer" : {"_value" : "2021-03-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1293256/answer/previousversion/87907", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} } , "questionFirstAnswered" : [{"_value" : "2021-03-08T15:17:57.063Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2021-03-08T17:53:34.43Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-03-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Hospitals: Admissions"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the proportion of people of hospital being treated for (a) covid-19 and (b) other reasons in each region of the UK in each of the last 12 months.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "160659"} , {"_about" : "http://data.parliament.uk/resources/1276868", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1276868/answer", "answerText" : {"_value" : "
The Government is committed to supporting research into Parkinson's disease, Alzheimer\u2019s disease and multiple sclerosis. The Department funds research into these areas through the National Institute for Health Research. Additionally, UK Research and Innovation funds research into these areas primarily through the Medical Research Council, the Biotechnology Biological Sciences Research Council, and the Economic and Social Research Council.<\/p>
The attached table shows funding allocated through these routes, not including wider funding that contributes to research in these areas. Figures for research into Alzheimer\u2019s disease are only part of overall dementia research spending.<\/p>
NIH<\/ins>R values refer to total spend. UKRI values refer to allocated / committed funding.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/1276868/answer/attachment/1", "fileName" : {"_value" : "PQ 137917 table formatted.docx"}
, "title" : "Funding"}
, "dateOfAnswer" : {"_value" : "2021-01-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1276868/answer/previousversion/77042", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/1276868/answer/previousversion/77042/attachment/1", "fileName" : {"_value" : "PQ 137917 table formatted.docx"}
, "title" : "Funding"}
}
, "questionFirstAnswered" : [{"_value" : "2021-01-26T10:04:42.777Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2021-03-04T10:12:02.513Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-01-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Alzheimer's Disease and Multiple Sclerosis: Research"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how much money from the public purse has been allocated to research into (a) Parkinson's disease, (b) Alzheimers Disease and (c) Multiple Sclerosis in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4076", "label" : {"_value" : "Biography information for Valerie Vaz"}
}
, "tablingMemberConstituency" : {"_value" : "Walsall South"}
, "tablingMemberPrinted" : [{"_value" : "Valerie Vaz"}
], "uin" : "137917"}
, {"_about" : "http://data.parliament.uk/resources/1276302", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1276302/answer", "answerText" : {"_value" : " Following agreeing the Trade and Cooperation Agreement (TCA) with the European Union, United Kingdom residents travelling to the EU will continue to be covered for necessary healthcare, and this includes kidney dialysis. The new Global Health Insurance Card (GHIC) covers necessary healthcare for UK residents visiting the UK. UK residents can apply online for the GHIC. Current European Health Insurance Cards (EHIC) will remain valid until the expiration date.<\/ins><\/p> Holders of current EHICs and the new GHIC are entitled to the same access to emergency and necessary healthcare cover when they travel to the EU, including cover for a pre-existing or chronic condition. In some countries, individuals may have to pay a percentage towards the cost of any state-provided treatment, known as a patient co-payment.<\/ins><\/p> As before, UK residents will need to pre-arrange kidney dialysis with the relevant healthcare provider in the country they are visiting.<\/ins><\/p> <\/p><\/ins><\/p> <\/p> The reciprocal healthcare coverage under the United Kingdom-European Union Trade and Cooperation Agreement for those on a temporary stay in an EU member state is the same, in terms of healthcare services which can be accessed by individuals, compared to the previous coverage under EU Regulations 883 and 987. However, under the UK-EU Trade and Cooperation Agreement, crew or passengers of a vessel or aircraft may now be covered for necessary healthcare on their arrival in an EU member state if the need arose whilst on a voyage, which is not the case under the EU Regulations.<\/p> The UK-EU Trade and Cooperation Agreement provides reciprocal healthcare coverage for travel to EU member states only. European Free Trade Area states are not covered. The UK Global Health Insurance Card has been launched to recognise this new agreement and will gradually replace old European Health Insurance Cards (EHIC) once they expire. <\/ins><\/p> Under the terms of the Withdrawal Agreement, UK nationals who were residing and/or working in the EU, and EU citizens residing and/or working in the UK, before 1 January 2021 are eligible to apply for a new UK EHIC which can be used for travel to EU member states, Switzerland, Norway, Iceland and Liechtenstein. For those who are not covered by the Withdrawal Agreement, the UK has agreed a bilateral reciprocal arrangement with Norway which means UK nationals are covered for necessary healthcare there.<\/ins><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2021-01-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1276338/answer/previousversion/74914", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
}
, "questionFirstAnswered" : [{"_value" : "2021-01-18T17:30:43.563Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2021-03-24T11:09:28.95Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-01-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Global Health Insurance Card"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what the differences in coverage of (a) countries and (b) services are between the European Health Insurance Card scheme and the UK Global Health Insurance Card; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4058", "label" : {"_value" : "Biography information for Paul Blomfield"}
}
, "tablingMemberConstituency" : {"_value" : "Sheffield Central"}
, "tablingMemberPrinted" : [{"_value" : "Paul Blomfield"}
], "uin" : "137184"}
, {"_about" : "http://data.parliament.uk/resources/1244554", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1244554/answer", "answerText" : {"_value" : " NHS England and NHS Improvement undertake regular monitoring of the demand and supply position for priority medicines including noradrenaline. A table showing this information is attached.<\/p> We cannot make accurate projections of demand going forward. However, we have used the information regarding first wave usage to inform mitigations for a second wave, such as stockpiling.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/1244554/answer/attachment/1", "fileName" : {"_value" : "2020 10 22 PQs 105571-72 Bristow attachment.xlsx"}
, "title" : "Noradrenaline demand and supply"}
, "dateOfAnswer" : {"_value" : "2020-10-28", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1244554/answer/previousversion/57690", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
}
, "questionFirstAnswered" : [{"_value" : "2020-10-28T16:09:55.227Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2020-11-11T14:29:56.35Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2020-10-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Noradrenaline"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the use of noradrenaline throughout the NHS in England in each month of 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4792", "label" : {"_value" : "Biography information for Paul Bristow"}
}
, "tablingMemberConstituency" : {"_value" : "Peterborough"}
, "tablingMemberPrinted" : [{"_value" : "Paul Bristow"}
], "uin" : "105571"}
, {"_about" : "http://data.parliament.uk/resources/1244555", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1244555/answer", "answerText" : {"_value" : " NHS England and NHS Improvement undertake regular monitoring of the demand and supply position for priority medicines including noradrenaline. A table showing this information is attached.<\/p> We cannot make accurate projections of demand going forward. However, we have used the information regarding first wave usage to inform mitigations for a second wave, such as stockpiling.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/1244555/answer/attachment/1", "fileName" : {"_value" : "2020 10 22 PQs 105571-72 Bristow attachment.xlsx"}
, "title" : "Noradrenaline demand and supply"}
, "dateOfAnswer" : {"_value" : "2020-10-28", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1244555/answer/previousversion/57691", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
}
, "questionFirstAnswered" : [{"_value" : "2020-10-28T16:09:55.273Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2020-11-11T14:29:47.863Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2020-10-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Noradrenaline"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has made an estimate of demand for noradrenaline during the remainder of 2020-21.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4792", "label" : {"_value" : "Biography information for Paul Bristow"}
}
, "tablingMemberConstituency" : {"_value" : "Peterborough"}
, "tablingMemberPrinted" : [{"_value" : "Paul Bristow"}
], "uin" : "105572"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 6, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
The reciprocal healthcare coverage under the United Kingdom-European Union Trade and Cooperation Agreement for those on a temporary stay in an EU member state is the same, in terms of healthcare services which can be accessed by individuals, compared to the previous coverage under EU Regulations 883 and 987. However, under the UK-EU Trade and Cooperation Agreement, crew or passengers of a vessel or aircraft may now be covered for necessary healthcare on their arrival in an EU member state if the need arose whilst on a voyage, which is not the case under the EU Regulations. <\/del><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2021-01-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1276302/answer/previousversion/74905", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
}
, "questionFirstAnswered" : [{"_value" : "2021-01-18T17:27:32.107Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2021-01-19T12:08:22.757Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-01-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Kidney Diseases: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people traveling in Europe who require it will continue to be able to access kidney dialysis treatment free of charge, following the UK\u2019s withdrawal from the European Health Insurance Card system.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4864", "label" : {"_value" : "Biography information for Olivia Blake"}
}
, "tablingMemberConstituency" : {"_value" : "Sheffield, Hallam"}
, "tablingMemberPrinted" : [{"_value" : "Olivia Blake"}
], "uin" : "137347"}
, {"_about" : "http://data.parliament.uk/resources/1276338", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1276338/answer", "answerText" : {"_value" : "